Quantum Biopharma (QNTM) Minority Interest (2023 - 2026)

Quantum Biopharma (QNTM) has 4 years of Minority Interest data on file, last reported at -$2.0 million in Q1 2026.

• For the quarter ending Q1 2026, Minority Interest fell 67.44% year-over-year to -$2.0 million; the trailing twelve-month figure through Mar 2026 stood at -$2.0 million (down 67.44% YoY), and the FY2025 full-year result was -$1.8 million, down 75.13% from the prior year.
• Minority Interest fell to -$2.0 million in Q1 2026, from -$1.8 million in the prior quarter.
• In the past five years, Minority Interest ranged from a high of -$89526.0 in Q3 2023 to a low of -$2.0 million in Q1 2026.
• A 4-year average of -$1.2 million and a median of -$1.1 million in 2025 frame the typical range for Minority Interest.
• Across the five-year window, Minority Interest slumped 954.77% in 2024 and declined 21.29% in 2025, its largest moves.
• Tracing QNTM's Minority Interest over 4 years: stood at -$89526.0 in 2023, then plunged by 1062.02% to -$1.0 million in 2024, then plunged by 75.13% to -$1.8 million in 2025, then decreased by 10.61% to -$2.0 million in 2026.
• Business Quant data shows QNTM's Minority Interest at -$2.0 million in Q1 2026, -$1.8 million in Q4 2025, and -$1.1 million in Q3 2025.